Description

SHORT DESCRIPTION:

Smart Immune is a clinical-stage biotechnology company focused on developing the next generation of hematopoietic stem cell-based biotherapies to change prognosis and life quality for patients with devastating diseases. The company’s first cell therapy program is based on T cell progenitors or ProTcellsTM (CD7+/CD34- ; CD5- cells) curative power to enable a short, polyclonal, and safe post-transplantation immune recovery. This program is completed by integrative developments from targeted conditioning to gene therapy and genome editing enabling clinicians to access new generation treatments for a wide variety of inherited blood disorders and blood cancers.

 

LONG DESCRIPTION:

Based in
Nation
Founded in

2017

Founding Status

$ 2.5 Millions - $ 5 Millions

mood_bad
  • No comments yet.
  • Add a review
      error: Content protected